Stocks in play: Aequus Pharmaceuticals Inc.
Has received a receipt for its final short form base shelf prospectus. The Prospectus will allow Aequus to offer up to $20,000,000 of common shares, preferred shares, debt securities, subscription receipts, units and warrants from time to time, in each of British Columbia, Alberta, Saskatchewan, Manitoba and Ontario, until the Prospectus expires on September 16, 2019. Aequus Pharmaceuticals Inc.